FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074659 [Registered on: 03/10/2024] Trial Registered Prospectively
Last Modified On: 19/09/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study comparing the impact of nebulised dexmedetomidine with nebulised lignocaine on blood pressure on intubation 
Scientific Title of Study   Randomised trial comparing the efficacy of pre-operative Nebulised Dexmedetomidine with Nebulised Lignocaine in attenuation of hemodynamic pressor response to laryngoscopy and nasotracheal intubation-A Phase II study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Pritha Raj 
Designation  Assistant Professor 
Affiliation  cancer institute 
Address  Room No.10, Department of Anesthesia Cancer institute WIA Sardar Patel Road Adyar Chennai

Chennai
TAMIL NADU
600020
India 
Phone  09840318716  
Fax    
Email  pritharaj1989@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Pritha Raj 
Designation  Assistant Professor 
Affiliation  cancer institute 
Address  Room No.10, Department of Anesthesia cancer institute wia sardar patel road adyar chennai

Chennai
TAMIL NADU
600020
India 
Phone  09840318716  
Fax    
Email  pritharaj1989@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr.Pritha Raj 
Designation  Assistant Professor 
Affiliation  cancer institute 
Address  Room No.10, Department of Anesthesia cancer institute wia sardar patel road adyar chennai

Chennai
TAMIL NADU
600020
India 
Phone  09840318716  
Fax    
Email  pritharaj1989@yahoo.co.in  
 
Source of Monetary or Material Support  
Cancer Institute WIA, Sardar Patel Road, Adyar, Chennai -600020 Tamilnadu 
 
Primary Sponsor  
Name  Cancer Institute WIA 
Address  Cancer Institute WIA Sardar patel road adyar chennai 600020 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrPritha Raj  cancer institute  Room No.10, Department of anesthesia Cancer Institute WIA, Sardar patel road, adyar, chennai-600020
Chennai
TAMIL NADU 
9840318716

prichink@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Cancer Institute (WIA) Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C00-D49||Neoplasms,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  nebulised dexmedetomidine  nebulisation done 10 minutes before induction 
Comparator Agent  nebulised lignocaine  nebulised lignocaine 10 minutes before induction 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  Adults, both male and female, aged above 18years, coming for surgery under general anesthesia needing nasotracheal intubation, classified under ASA 1,2 status 
 
ExclusionCriteria 
Details  presence of heart block, asa 3-4, drug allergy to propofool, egg, cardiac dysfunction 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Comparison of the efficacy of nebulised dexmedetomidine with nebulised lignocaine on attenuation of systolic blood pressure in patients undergoing laryngoscopy and nasotracheal intubation  before drug administration, induction and 10 minutes after nasotracheal intubation 
 
Secondary Outcome  
Outcome  TimePoints 
the effect of nebulised dexmed/lignocaine on heart rate, BP, sedation score, need for additional drugs to maintain hemoodynamic stability, the mean of the pre induction and post intubation HR, Mean arterial pressure and diastolic bp shall be compared, mean propofol requirement between the 2 groups shall be compared  pre drug, induction and 10 minutes post intubation 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Endotracheal intubation is  a highly stimulating procedure associated  with a surge in catecholamine levels and significant hemodynamic  alterations which may adversely impact postoperative outcomes, especially in patients with multiple comorbidities.Nasotracheal intubation has been found to be more hemodynamic changes due to the involvemnt of highly sensitive structures. Multiple drugs have been used but no ideal drug has been identified. Nebulised dexmedetomidine offers a novel solution to using its properties in attenuating the hemodynamic changes without any of its side effects. Nebulised lignocaine also has been studied extensively wrt to its effect on blunting the intubation response. However, these drugs have not been compared for their effects on nasotracheal intubation. It is being hypothesised that nebulised dexmedetomidine may be more effective than nebulised lignocaine based on previous research. 
Close